NASDAQ · TRNS
Industrials · Specialty Business Services
$89.91▲ 1.18% ($1.05)today
As of 3:06 PM ET
Market cap
$841.54M
P/E
247.16
EPS (TTM)
$0.36
Next earnings
Valuation
Verdict: expensive. Price above all scenarios.
The price needs 28.6% revenue growth a year for 10 years. Our scenarios assume 7.0–12.2%.
That's 2.2× its past 4-year pace.
Value per share
Base case
$17.36
Price used $89.91 is 5.2× this
USD · TTM ending Jun 27, 2026 · Price Oct 29, 7:06 PM UTC
Revenue each value needs
Revenue today $348M. The price needs $4.3B by 2036. Base case: $883M. At its recent pace: $1.2B. Bear to Bull: $687M to $1.1B.
$4.3B
What the price needs
28.6% a year · by 2036
$1.2B
At its recent pace
12.8% a year
+$3.4B
more revenue in 2036 than the Base case expects
$883M
Base case → $17.36/share
Revenue today $348M. The price needs $4.3B by 2036. Base case: $883M. At its recent pace: $1.2B. Bear to Bull: $687M to $1.1B.
Revenue in 2036
today $348M
+$3.4Bmore than the Base case · 4.9×
Value per share · Base case
$17.36
Price $89.91
5.2× this
USD · TTM ending Jun 27, 2026 · Price Oct 29, 7:06 PM UTC
What each scenario assumes. Click a column to start from it.
Price vs Fundamentals
The stock rose 21.31% over the last year. Revenue grew 20.17% over the trailing twelve months. Operating margin moved from 7.36% to 3.02%. Free cash flow grew 29.51% over the trailing twelve months.
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 42nd percentile of their historical P/FCF range.
Operating margin is at 3.02%. Revenue grew 20.17% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation.
Market multiples
Stock splits
Every 1 shares became 2
Every 1 shares became 2
Every 1 shares became 2
Profitability & growth
Analyst consensus
9
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Actuals vs estimates by quarter, or any quarter against the same one a year earlier.
Next report
Nov 3, 2026
Q2 FY27 · EPS est $0.45 · Revenue est $92.5M
Same quarter, year over year
FY27 YTD -76.3%Each cell vs the same quarter a year earlier (the cell below) · Q1 combined $0.14 vs $0.59 · 0 of 1 quarters up
Q1
Q2
Q3
Q4
FY total
FY27
—
—
—
FY26
FY25
FY24
—
—
Fiscal year totals
Q1 FY27
Reported Aug 4, 2026 · Latest
HoverTap a cell to inspect
Actual
$0.14
Estimate
$0.38
Year over year
-76.3%
Vs prior quarter
-75.0%
Transcat, Inc. · TRNS
From Form 13F filings (managers with $100M+). Filings land up to 45 days after quarter end — read this as positioning context, not live fund flow.
Nov 3, 2026